The Impact of Brexit on Pharmaceuticals and HTA
Open Access
- 20 March 2018
- journal article
- editorial
- Published by Springer Nature in PharmacoEconomics - Open
- Vol. 2 (2) , 87-91
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Editorial: maintaining open access to high quality publications at no cost to authorsBritish Journal of Pharmacy, 2017
- How will Brexit affect health and health services in the UK? Evaluating three possible scenariosThe Lancet, 2017
- How will NICE's budget impact test affect new drug availability?Prescriber, 2017
- How do we avoid disaster when exiting the European Medicines Agency? Making the most of Brexit in pharmaceutical regulationecancermedicalscience, 2017
- The National Health Service at a Critical Moment: when Brexit means HecticJournal of Social Policy, 2017
- Overview of external reference pricing systems in EuropeJournal of Market Access & Health Policy, 2015
- Health economics in the UK: Capacity, constraints and comparisons to US health economistsInternational Review of Economics Education, 2013
- Expected value of information and decision making in HTAHealth Economics, 2006
- Good Practice Guidelines for Decision-Analytic Modelling in Health Technology AssessmentPharmacoEconomics, 2006
- Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysisHealth Economics, 1994